Key result
Giant miniature endplate potentials are Ca+2-independent and increase in frequency in weakened muscles, suggesting a neurotrophic mechanism to preserve neuromuscular transmission.
Giant miniature endplate potentials may represent a neurotrophic mechanism to preserve neuromuscular transmission when normal function is compromised.
May support compensatory mechanisms in neuromuscular weakness; leaves open targeted validation in prospective studies.
An unusually large amplitude spontaneous miniature endplate potentials (gMEPPs) occur naturally at low frequency at the vertebrate neuromuscular junction. Unlike the normal miniature endplate potentials (nMEPPs ), these gMEPPs have long duration and long time to peak. More strikingly, gMEPPs seem to be independent of extracellular and intracellular Ca +2. and have a greater temperature sensitivity than nMEPPs. They are potentiated by tetrodotoxin but inhibited by acetylcholine (ACh) receptor blockers indicating ACh is the neurotransmitter responsible for gMEPPs. The frequency of gMEPPs is greatly increased in muscles weakened by various drugs, toxins or disease conditions suggesting that gMEPPs may be a part of possible neurotrophic mechanism to preserve effective neuromuscular transmission when the normal function is compromised.
No takes yet. Share an insight, caveat, or question.
Karim A. Alkadhi (2024) conducted a review in Neuromuscular junction function. Giant miniature endplate potentials (gMEPPs) vs. Normal miniature endplate potentials (nMEPPs) was evaluated. Giant miniature endplate potentials are Ca+2-independent and increase in frequency in weakened muscles, suggesting a neurotrophic mechanism to preserve neuromuscular transmission.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: